Publications

Advancing Mathematical Models of Mycobacterium tuberculosis Transmission to Support Vaccine Introduction.

WEERASURIYA, CK;

2022

(2022). 10.17037/PUBS.04665244.

Understanding the biology, morbidity and social contexts of adolescent tuberculosis: a prospective observational cohort study protocol (Teen TB).

Swanepoel, J; Zimri, K; Van der Zalm, MM; Hoddinott, G; Palmer, M; Doruyter, A; De Beer, G; Kleynhans, L; Johnson, SM; Jongen, V; Wademan, D; Mcimeli, K; Jacobs, S; Swanepoel, R; Van Zyl, G; Allwood, BW; Malherbe, S; Heuvelings, C; Griffith-Richards, S; Whittaker, E; MOORE, DA J; Schaaf, HS; Hesseling, AC; Seddon, JA;

2022

BMJ Open, (2022).12 12 10.1136/bmjopen-2022-062979.

Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts.

Williams, CM; Muhammad, AK; Sambou, B; Bojang, A; Jobe, A; Daffeh, GK; Owolabi, O; Pan, D; Pareek, M; Barer, MR; SUTHERLAND, JS; Haldar, P;

2022

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2022).76 3 10.1093/cid/ciac455.

A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates.

Fowler, PW; Wright, C; Spiers, H; Zhu, T; Baeten, EM L; Hoosdally, SW; Gibertoni Cruz, AL; Roohi, A; Kouchaki, S; Walker, TM; Peto, TE A; Miller, G; Lintott, C; Clifton, D; Crook, DW; Walker, AS; Zooniverse Volunteer Community,; CRyPTIC Consortium,;

2022

eLife, (2022).11, 10.7554/eLife.75046.

Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.

Finci, I; Albertini, A; Merker, M; Andres, S; Bablishvili, N; Barilar, I; Cáceres, T; Crudu, V; Gotuzzo, E; Hapeela, N; Hoffmann, H; Hoogland, C; Kohl, TA; KRANZER, K; Mantsoki, A; Maurer, FP; Nicol, MP; Noroc, E; Plesnik, S; Rodwell, T; Ruhwald, M; Savidge, T; Salfinger, M; Streicher, E; Tukvadze, N; ... Denkinger, CM.

2022

The Lancet Microbe, (2022).3 9 10.1016/S2666-5247(22)00116-1.

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.

Kochhar, S; Barreira, D; Beattie, P; Cavaleri, M; Cravioto, A; Frick, MW; Ginsberg, AM; Hudson, I; Kaslow, DC; Kurtz, S; Lienhardt, C; Madhi, SA; Morgan, C; Momeni, Y; Patel, D; Rees, H; Rogalski-Salter, T; Schmidt, A; Semete-Makokotlela, B; Voss, G; WHITE, RG; Zignol, M; Giersing, B;

2022

Vaccine, (2022).40 12 10.1016/j.vaccine.2021.10.062.

Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.

Kim, HW; Park, S; Min, J; Sun, J; Shin, AY; Ha, JH; Park, JS; Lee, S-S; Lipman, M; Abubakar, I; STAGG, HR; Kim, JS;

2022

Scientific reports, (2022).12 1 10.1038/s41598-022-16441-7.

REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk.

Shah, JA; Warr, AJ; Graustein, AD; Saha, A; Dunstan, SJ; Thuong, NT T; Thwaites, GE; Caws, M; Thai, PV K; Bang, ND; Chau, TT H; Khor, CC; Li, Z; HIBBERD, M; Chang, X; Nguyen, FK; Hernandez, CA; Jones, MA; Sassetti, CM; Fitzgerald, KA; Musvosvi, M; Gela, A; Hanekom, WA; Hatherill, M; Scriba, TJ; ... Hawn, TR.

2022

The Journal of Immunology, (2022).208 6 10.4049/jimmunol.2100671.

Comparing the performance of QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube among highly TB exposed gold miners in South Africa.

Ntshiqa, T; Chihota, V; Mansukhani, R; Nhlangulela, L; Velen, K; Charalambous, S; Maenetje, P; Hawn, TR; Wallis, R; GRANT, AD; Fielding, K; Churchyard, G;

2022

Gates Open Research, (2022).5, 10.12688/gatesopenres.13191.2.

Improving estimates of social contact patterns for the airborne transmission of respiratory pathogens.

MCCREESH, N; Mohlamonyane, M; Edwards, A; Olivier, S; Dikgale, K; Dayi, N; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K;

2022

(2022). 10.1101/2022.02.06.22270386.